Contract drug manufacturer Lonza plans to double Swiss production capacity for Moderna's COVID-19 vaccine, helping the U.S. drugmaker boost total output to as many as 3 billion doses in 2022.
https://www.marketscreener.com/quote/stock/LONZA-GROUP-AG-2956013/news/Lonza-nbsp-Switzerland-s-Lonza-to-boost-production-for-Moderna-COVID-19-vaccine-33102343/
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.